Preferred Pharmaceuticals recalls 15mg Lansoprazole Capsules due to dissolution issues
Preferred Pharmaceuticals is recalling 15mg Lansoprazole Delayed-Release Capsules (90-count) after stability testing showed dissolution problems. This may affect drug effectiveness.
Lower-risk recall
Out of specification results observed in dissolution during long term stability testing.
Contact the company
What happened, in plain English
Preferred Pharmaceuticals is recalling 15mg Lansoprazole Delayed-Release Capsules (90-count) because stability testing found dissolution issues. This could mean the medication doesn't work as intended. Read more at govinfonow.com/recall/35042-preferred-pharmaceuticals-recalls-15mg-lansoprazole-capsules-due-to-dissolution-issues.
Source Summary by GovInfoNow · govinfonow.com/recall/35042-preferred-pharmaceuticals-recalls-15mg-lansoprazole-capsules-due-to-dissolution-issues · Updated August 18, 2026 · FDA enforcement record: FDA #D-0769-2022
Cite this page
“Preferred Pharmaceuticals recalls 15mg Lansoprazole Capsules due to dissolution issues.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35042-preferred-pharmaceuticals-recalls-15mg-lansoprazole-capsules-due-to-dissolution-issues. Based on FDA recall #D-0769-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0769-2022%22&limit=1).
Why it’s dangerous
The recall is based on stability testing showing dissolution problems. This means the medication might not release the active ingredient properly over time, potentially reducing its effectiveness.
Who’s affected
People who purchased the 15mg Lansoprazole Delayed-Release Capsules (90-count) from Dr Reddy's Laboratories Limited. Those with acid reflux conditions are most at risk if the medication doesn't work properly.
How to tell if you have this one
Check for the 90-count bottle labeled 'Lansoprazole Delayed-Release Capsules, 15mg' with NDC 68788-6390-09. The product was sold by Dr Reddy's Laboratories Limited with specific lot numbers and expiration date 12/31/2023.
- Brand
Preferred Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Look for the NDC code 68788-6390-09 on the bottle label to confirm if it's recalled.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA and CA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 43 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is there a risk of serious injury from this product?
The recall is for potential reduced effectiveness, not a safety hazard causing injury.
Similar recalls
Other Preferred Pharmaceuticals recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0769-2022 (March 28, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0769-2022 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.